Microdosing For Anxiety: Important Info To Know Before Trying It
Last reviewed and updated: June 1, 2026.
Key Takeaways
| What it is | Taking 1/10–1/20 of a full psychedelic dose to achieve subtle cognitive or mood effects without a full psychedelic experience |
| Evidence for anxiety | Mixed — some studies show reduced anxiety, others find microdosing can worsen anxiety symptoms, particularly when anxiety is the primary diagnosis |
| Legal status | Not legal for self-administration in the U.S.; psilocybin decriminalized in some cities; Oregon/Colorado run supervised full-dose programs only |
| Key risk | Unpredictable dosing, variable individual responses, and potential anxiety amplification — especially without medical supervision |
| Legal alternatives | Ketamine therapy (nationwide), esketamine/Spravato (FDA-approved), psilocybin clinical trials at Johns Hopkins/NYU (free enrollment) |
Having anxiety is a traumatic experience, no matter how mellow or severe. It’s why many people look for innovative ways to combat symptoms — like microdosing for anxiety, as psychedelics drugs gain popularity.
Microdosing refers to using small doses of psychedelics to stimulate the brain. This typically keeps anxious thoughts from creeping in, avoiding stress and negativity. Using about 1/10 or 1/20 of a regular dose, the goal is to achieve the positive results of hallucinogenic substances without the full experience.
Research has shown how effective microdosing can be for those struggling with anxiety, depression, PTSD, and even addiction. Before deciding to try it, however, here is important info to know.
RELATED: How To Start Microdosing Psychedelics: A Beginner’s Guide
Most Psychedelics Are Still Illegal
Most psychedelics are still illegal to purchase, so finding a way to administer them might not be easy. Studies and volunteer programs are available, but without official evaluation to prove a person suffers from anxiety, it may be hard to sign up.
Even after Oregon state deemed psilocybin legal in a therapeutic setting, it can still only be administered under strict supervision. This only comes after licensed psychotherapists conclude a rigorous exam and evaluation.
RELATED: Mommy-Dosing: Why Are So Many Moms Microdosing Psychedelics?
Not All Doses Are For Everyone
The right dosage differs from person to person, depending on age, weight, mental state, sensitivity to substances, allergies, nutrition choices, and even fitness level. Yes, these all contribute to how the psychedelics can act in a person’s bloodstream.
Anyone Can Have a Bad Trip While Microdosing for Anxiety
Having a negative experience , or a “bad trip”, while taking psychedelics can be common. It can happen to anyone, anytime, anywhere. So before microdosing for anxiety, it’s important to prepare yourself for.
That negative experience can also be different for different people. While some may only get mild symptoms like headaches, gastrointestinal issues, or troubles with sleeping and bloating, others may report severe hallucinations, fever, vomiting, and an increased state of fear, usually caused by past traumatic experiences. Nobody can predict how a psychedelic experience will go, so always prepare with awareness.
Prior to microdosing psychedelics, be sure to safely have someone around to assist should anything happen. This person should be trusted by you, and can help decrease the severity of any negative responses.
RELATED: What Does Anxiety Feel Like?
Microdosing for Anxiety Isn’t Always Consistent Each Time
Depending on the state you’re in, prepare to experience microdosing differently every time you do it. Psychedelics may impact the body differently every time. And just because a bad trip didn’t happen the first time, doesn’t mean it won’t happen on the second.
Be aware of the different factors that play a role in microdosing. This will ensure safety and bring peace of mind to expect the unexpected.
Experiencing Contra Effects
The reason you’re interested in trying microdosing is because of the reported positive effect it has on anxiety. Still, in some people, psychedelics may even cause increased anxiety. It has more to do with the preexisting conditions than the drug itself, as those who are more sensitive to stimulants can react with unwanted consequences.
There’s Still A Lot Of Unknown
Due to the current status of psychedelics and the lack of formal studies, there are still lots of unknowns. Even as the majority of studies show positive results, psychedelic therapy has not yet been fully accepted for fighting anxiety, depression, PTSD, and other mental health issues.
Many privatized companies are conducting research on their own. These large-scale studies will be able to provide information to better explain the impact of hallucinogenic substances. This will also help describe how psychedelics combat mental health problems.
Also Read: Four apps to help you track microdosing
Do Your Research
As with everything new, do your due diligence to learn all there is to know about microdosing trying it. The internet can be a great source of information, but also a very conflicting place, especially with topics this controversial. Check out the professional resources such as those offered by the John Hopkins Center for Psychedelic and Consciousness Research, or the California Center for Psychedelic Therapies and Research and arm yourself with as much information as possible so you know exactly what you can expect.
These organizations list all the currently updated information on psychedelics as well as published studies, current trials, ways to apply for evaluation, and which centers have licensed medical professionals on staff.
Microdosing for Anxiety Can Be Scary
Before microdosing psychedelics, it’s important to remember they are powerful substances which can have serious side effects; both short and long term. Keep in mind that they’re not placebo pills which will trick your mind into thinking they’re helping when they actually aren’t. They are real, plant-derived, hallucinogenic compounds which when administered cause reactions — no matter how mellow you might experience them.
Although early studies show microdosing psychedelics may help improve mood and focus, more information is necessary. So it’s important to research and educate yourself on how these hallucinogenic substances actually work once entering your bloodstream.
What the Research on Microdosing for Anxiety Actually Shows in 2025
The cautions above reflect legitimate uncertainties — particularly around legal access, variable dosing, and unpredictable responses. But the research landscape has advanced considerably since this article was first published, and it’s worth understanding what clinical evidence actually says before deciding whether microdosing for anxiety is appropriate for you.
What Studies Show
The largest naturalistic study on microdosing to date — published in Scientific Reports in 2021 — followed 953 microdosers over 30 days alongside 180 non-microdosing controls. Microdosers reported significantly lower levels of anxiety and depression, and higher levels of well-being. However, this was a self-selected sample with no blinding, meaning strong expectation effects cannot be ruled out. A 2022 Imperial College London study published in eLife used a “self-blinding” protocol and found improvements in anxiety and depression in microdosers — but comparable improvements in the placebo group as well, suggesting that expectation plays a meaningful role in outcomes. James Fadiman, one of the earliest microdosing researchers, has specifically noted that individuals with anxiety as their primary symptom may find that microdosing worsens their anxiety rather than relieves it — a finding the 2019 Journal of Psychoactive Drugs study corroborated.
Legal Access Has Expanded — But Remains Limited
Oregon’s legal psilocybin service centers (open since 2023) and Colorado’s facilitator programs (2025) do not offer microdosing specifically — they administer full-dose sessions in supervised settings. Access to legal microdosing outside of a clinical trial remains extremely limited in the United States. The practical reality for most people is that any microdosing still occurs in a legally grey or illegal context, which shapes risk and safety considerations significantly. If legal access is a priority, the clearest path for anxiety treatment remains ketamine therapy, which is legal nationwide, well-insured in some cases (Spravato/esketamine), and supported by extensive clinical evidence.
The Bottom Line on Microdosing for Anxiety
The research is genuinely mixed. For some people, particularly those with depression alongside anxiety, the evidence for benefit is stronger. For anxiety as a primary symptom, the evidence is more complicated — and at least some studies suggest microdosing can amplify rather than reduce anxious states. Anyone seriously considering microdosing for anxiety should read the published literature, understand the legal context in their jurisdiction, consult a psychiatric provider who is familiar with psychedelic medicine, and understand that “sub-perceptual” dosing is harder to achieve in practice than it sounds.
RELATED READING
- Microdosing LSD: What The Research Actually Shows
- What Is Psychedelic Therapy? Here’s What The Research Says
- Is Ketamine Therapy Safe? What The Evidence Says
Frequently Asked Questions
Can microdosing make anxiety worse?
Yes — this is one of the more consistent findings in the microdosing research literature. James Fadiman, who conducted some of the earliest self-report studies on microdosing, specifically cautioned that individuals with anxiety as their primary symptom may experience worsening rather than relief. A 2019 study in the Journal of Psychoactive Drugs found increased neuroticism — a trait linked to experiencing negative emotions — in some microdosers. A 2020 European Neuropsychopharmacology placebo-controlled study also found that microdosing LSD increased anxiety at some dose levels. This doesn’t mean microdosing always worsens anxiety, but it’s a real enough risk that anyone with primarily anxiety symptoms should approach it more cautiously than someone whose primary issue is depression.
Is microdosing for anxiety legal anywhere in the U.S.?
Microdosing specifically (as opposed to full-dose supervised sessions) is not formally legal for self-administration anywhere in the United States. Oregon and Colorado have legal psilocybin programs, but these require licensed facilitators and administer full doses — not microdoses — in supervised settings. Psilocybin possession has been decriminalized in several cities (Denver, Oakland, Seattle, Ann Arbor, DC, and others), meaning low-level possession is deprioritized by law enforcement but not technically legal. The legal route to psychedelic-assisted anxiety treatment in the U.S. is currently through ketamine (legal nationwide), FDA-approved esketamine (Spravato), or enrollment in a clinical trial.
How do you determine the right microdose?
There’s no established clinical standard for microdosing because it hasn’t received formal regulatory approval for any condition. In research settings, a microdose is typically defined as 1/10th to 1/20th of a full dose — roughly 1–3mg of psilocybin or 5–20mcg of LSD. In practice, the right dose varies significantly between individuals based on body weight, metabolism, prior psychedelic experience, and mental state. The absence of a perceptual effect is the traditional target (hence “sub-perceptual”). Achieving that reliably at home with imprecise supply is genuinely difficult, which is one of the practical risks the research community consistently flags.
Are there any legal alternatives to microdosing for anxiety?
Yes — ketamine therapy is the closest legal analog, particularly for treatment-resistant anxiety disorders. FDA-approved esketamine (Spravato) is specifically indicated for major depressive disorder with acute suicidal ideation, and IV ketamine is legally available at over 1,800 clinics nationwide for off-label anxiety and depression use. Clinical trials for psilocybin-assisted therapy for generalized anxiety disorder (GAD) are actively recruiting. These trials provide legal, supervised access to psilocybin — including through Johns Hopkins and NYU’s ongoing programs. Oregon’s legal psilocybin service centers provide another legal option if you’re able to travel to Oregon for a supervised full-dose session.
